TY  - GEN
AU  - Džavík,Vladimír
AU  - Kaul,Upendra
AU  - Guagliumi,Guilio
AU  - Chevalier,Bernard
AU  - Smits,Peter C
AU  - Stuteville,Marrianne
AU  - Li,Dong
AU  - Sudhir,Krishnankutty
AU  - Grube,Eberhard
TI  - Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study
SN  - 1522-726X
PY  - 2014///0418
KW  - Asia
KW  - Canada
KW  - Cardiovascular Agents
KW  - administration & dosage
KW  - Coronary Angiography
KW  - Coronary Artery Disease
KW  - diagnosis
KW  - Coronary Thrombosis
KW  - etiology
KW  - Drug-Eluting Stents
KW  - Europe
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - New Zealand
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Platelet Aggregation Inhibitors
KW  - therapeutic use
KW  - Prospective Studies
KW  - Prosthesis Design
KW  - Risk Factors
KW  - Sirolimus
KW  - South Africa
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ccd.24775
ER  -